We propose PRL3-DDX21 regulation of productive transcription elongation functions as a fine-tuning mechanism for matching the regenerative response with tissue needs and an opportunity for specifically targeting cancer cells in a non-regenerative setting. Here, DDX21 is linked to cancer.